Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
Mallinckrodt
US Army
Healthtrust
Merck
Baxter
Cantor Fitzgerald
Chubb
Dow

Generated: October 21, 2017

DrugPatentWatch Database Preview

MOXAM Drug Profile

« Back to Dashboard

What is the patent landscape for Moxam, and when can generic versions of Moxam launch?

Moxam is a drug marketed by Lilly and is included in one NDA.

The generic ingredient in MOXAM is moxalactam disodium. There is one drug master file entry for this compound. Additional details are available on the moxalactam disodium profile page.

Summary for Tradename: MOXAM

US Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list29
Patent Applications: see list1,852
Drug Prices:see details
DailyMed Link:MOXAM at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lilly
MOXAM
moxalactam disodium
INJECTABLE;INJECTION050550-003Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
MOXAM
moxalactam disodium
INJECTABLE;INJECTION050550-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
MOXAM
moxalactam disodium
INJECTABLE;INJECTION050550-004Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
MOXAM
moxalactam disodium
INJECTABLE;INJECTION050550-008Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Lilly
MOXAM
moxalactam disodium
INJECTABLE;INJECTION050550-002Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Medtronic
US Department of Justice
Merck
Cipla
Accenture
Fuji
UBS
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot